Grail, Inc. (NASDAQ: GRAL)

This lawsuit is for anyone who acquired securities in Grail, Inc. (NASDAQ: GRAL) from May 13, 2025 through February 19, 2026.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by telling investors that the Company’s developmental test for the early detection of cancer showed promise in early clinical trials while failing to tell investors that the clinical trials needed to run for a long enough period of time to determine whether the test actually worked.

On February 19, 2026, Grail announced that the “primary endpoint of statistically significant Stage III-IV [cancer] reduction was not observed” in its NHS-Galleri Trial due, in part, to “probably need[ing] a longer follow-up time to be able to [compare the study arms] adequately.” On this news, the price of the Company’s stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Grail, Inc. (NASDAQ: GRAL) from May 13, 2025 through February 19, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.